Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Santarem

8 clinical trials in Santarem, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Santarem at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Santarem

Open in trial search

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Medisch Centrum Utrecht

Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dermatophagoides farinae enriched allergoid, mannan-conjugated, polymerised
  • Sponsor:Inmunotek S.L.

Study on the Effectiveness and Safety of Sublingual MM09 for Patients Aged 12-65 with Allergies to House Dust Mites and Rhinitis/Rhinoconjunctivitis with or without Asthma

Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dermatophagoides Farinae Extract
  • Sponsor:Inmunotek S.L.

IgA nephropathy

Recruiting

Study on Atrasentan for Patients with IgA Nephropathy at Risk of Kidney Function Loss

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Zigakibart
  • Sponsor:Novartis Pharma AG

Chronic kidney disease+1

Not recruiting

A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years
  • Substances:BAY 3401016
  • Sponsor:Bayer AG

Diabetic retinopathy+1

Not recruiting

Study on the Effectiveness and Safety of BAY 3283142 in Reducing Urine Albumin for Patients with Chronic Kidney Disease

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:BAY 3283142
  • Sponsor:Bayer AG

Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Santarem

What the registry says about research in the country

01 Allergy & Immunotherapy Research

Innovative clinical research focusing on sublingual immunotherapy for patients affected by allergies to house dust mites. This study examines treatment options for individuals experiencing rhinitis and rhinoconjunctivitis, with special attention to cases complicated by mild to moderate asthma.

  • Respiratory Allergies
  • Immunotherapy Development
  • Asthma Management

The research aims to evaluate a novel therapeutic approach for managing moderate to severe allergic conditions, potentially offering new hope for allergy sufferers seeking long-term relief from their symptoms.

02 Respiratory Medicine

Comprehensive investigation into the treatment of rhinitis and rhinoconjunctivitis, focusing on patients with varying severity levels. The research explores the intersection between upper respiratory allergies and asthma management.

  • Upper Respiratory Treatment
  • Combined Symptom Management
  • Therapeutic Efficacy

This multicenter trial represents a significant step forward in understanding the relationship between allergic responses and respiratory conditions.

03 Precision Medicine

Advanced clinical research targeting specific allergen responses to Dermatophagoides species. The study employs precise dosing strategies to evaluate treatment effectiveness across different age groups.

  • Targeted Therapy
  • Age-Specific Response
  • Long-term Effectiveness

The research focuses on developing personalized treatment approaches for patients aged 12-65 years, addressing both intermittent and persistent allergic conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.